Extract from the Register of European Patents

EP Citations: EP3102225

Cited inSearch
Type:Patent literature
Publication No.:WO0145712  [X]
 (BAYER AG et al.) [X] 1,2 * pages 58-59,69; claim 13 *
Type:Patent literature
Publication No.:WO2014106019  [XPY]
 (PHILADELPHIA HEALTH & EDUCATIO et al.) [XP] 1-5 * page 128, paragraph 379 * * pages 238-238, paragraph 670 *[Y] 1-18
Type:Patent literature
Publication No.:WO2014165128  [XPY]
 (NOVIRA THERAPEUTICS INC et al.) [XP] 1-4 * pages 3,4 *[Y] 1-18
Type:Patent literature
Publication No.:WO2015172128  [E]
 (UNIV INDIANA RES & TECH CORP et al.) [E] 1-5 * pages 6,20 * * pages 17-18, paragraphs 30-32 *
Type:Patent literature
Publication No.:WO2015118057  [E]
 (JANSSEN SCIENCES IRELAND UC et al.) [E] 1,2 * page 19 *
Cited inInternational search
Type:Patent literature
Publication No.:WO2013096744  [X]
 (NOVIRA THERAPEUTICS INC et al.) [X] 1-9, 11-15, 17, 18 * , abstract, pp. 4-8, 23-24, 159, 160, 171-176 *
Type:Patent literature
Publication No.:WO9823285  [A]
 (SMITHKLINE BEECHAM PLC et al.) [A] 1-9, 11-15, 17, 18 * , claims 3, 12 *
Type:Non-patent literature
Publication information:[A]   CAMPAGNA, MATTHEW R. ET AL.: "Sulfamoylbenzamide Derivatives Inhibit the Assembly of Hepatitis B Virus Nucleocapsids.", JOURNAL OF VIROLOGY, vol. 87, no. 12, pages 6931 - 6942, XP055153462
DOI: http://dx.doi.org/10.1128/JVI.00582-13